Researchers from the University of Kentucky Markey Cancer Center have shared encouraging early results from a new clinical ...

Antibody-drug conjugates and their development remains a central theme in ongoing research within the realm of ovarian cancer ...

University of Kentucky Markey Cancer Center researchers presented promising results from an early-stage clinical trial ...

Prof. Kunle Odunsi has been named the speaker for the University of Chicago’s Convocation ceremony on June 7.

Cash and cash receivable balance of $20.9 million as of December 31, 2024, expected to fund operations, including clinical activities ...

Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy ...

Positive azenosertib clinical data demonstrated clinically meaningful results in patients with Cyclin E1+ platinum-resistant ovarian cancer ...

The University of Pennsylvania has taken a novel approach to ensure that women with suspicious adnexal lesions are referred ...

The addition of pembrolizumab to chemoradiotherapy improved survival outcomes for women with high-risk, locally advanced ...

Last week, Smith and her colleagues presented work at a Society of Gynecologic Oncology meeting proposing a new lower threshold for the blood test that would work better across all populations.

Please provide your email address to receive an email when new articles are posted on . Results showed an objective response rate of 100% and a 12-month PFS of 74.9%. AK104 with concurrent ...

Last week, Smith and her colleagues presented work at a Society of Gynecologic Oncology meeting proposing a new lower threshold for the blood test that would work better across all populations.